» Articles » PMID: 29388131

Extracellular RNAs: A New Awareness of Old Perspectives

Abstract

Extracellular RNA (exRNA) has recently expanded as a highly important area of study in biomarker discovery and cancer therapeutics. exRNA consists of diverse RNA subpopulations that are normally protected from degradation by incorporation into membranous vesicles or by lipid/protein association. They are found circulating in biofluids, and have proven highly promising for minimally invasive diagnostic and prognostic purposes, particularly in oncology. Recent work has made progress in our understanding of exRNAs-from their biogenesis, compartmentalization, and vesicle packaging to their various applications as biomarkers and therapeutics, as well as the new challenges that arise in isolation and purification for accurate and reproducible analysis. Here we review the most recent advancements in exRNA research.

Citing Articles

Adapted Exosomes for Addressing Chemotherapy-induced Premature Ovarian Insufficiency.

Mousaei Ghasroldasht M, Park H, Ali F, Beckman A, Mohammadi M, Hafner N Stem Cell Rev Rep. 2025; .

PMID: 39921838 DOI: 10.1007/s12015-024-10820-5.


The Role of Exosomes in Cancer Progression and Therapy.

Sergazy S, Seydahmetova R, Gulyayev A, Shulgau Z, Aljofan M Biology (Basel). 2025; 14(1).

PMID: 39857258 PMC: 11763171. DOI: 10.3390/biology14010027.


Exosomal long non-coding RNAs in lung cancer: A review.

Jiang J, Lin F, Wu W, Zhang Z, Zhang C, Qin D Medicine (Baltimore). 2024; 103(51):e38492.

PMID: 39705424 PMC: 11666185. DOI: 10.1097/MD.0000000000038492.


Stress-induced extracellular vesicles: insight into their altered proteomic composition and probable physiological role in cancer.

Bhavsar V, Sahu A, Taware R Mol Cell Biochem. 2024; .

PMID: 39302488 DOI: 10.1007/s11010-024-05121-x.


Exosomal mRNA Cargo are biomarkers of tumor and immune cell populations in pediatric osteosarcoma.

Ong J, Jalaludin N, Wong M, Tan S, Angelina C, Sukhatme S Transl Oncol. 2024; 46:102008.

PMID: 38852279 PMC: 11220529. DOI: 10.1016/j.tranon.2024.102008.


References
1.
Hutvagner G, Zamore P . A microRNA in a multiple-turnover RNAi enzyme complex. Science. 2002; 297(5589):2056-60. DOI: 10.1126/science.1073827. View

2.
Rodriguez A, Griffiths-Jones S, Ashurst J, Bradley A . Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004; 14(10A):1902-10. PMC: 524413. DOI: 10.1101/gr.2722704. View

3.
Nielsen C, Shomron N, Sandberg R, Hornstein E, Kitzman J, Burge C . Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. RNA. 2007; 13(11):1894-910. PMC: 2040081. DOI: 10.1261/rna.768207. View

4.
Filipowicz W, Bhattacharyya S, Sonenberg N . Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet. 2008; 9(2):102-14. DOI: 10.1038/nrg2290. View

5.
Mitchell P, Parkin R, Kroh E, Fritz B, Wyman S, Pogosova-Agadjanyan E . Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008; 105(30):10513-8. PMC: 2492472. DOI: 10.1073/pnas.0804549105. View